Cargando…
Adding Colchicine to the Antiretroviral Medication - Lopinavir/Ritonavir (Kaletra) in Hospitalized Patients with Non-Severe Covid-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomized Controlled Trial
OBJECTIVES: Colchicine is a well-known drug, which has been used for years to treat a wide range of rheumatic and inflammatory disorders. It helps break the cycle of inflammation through diverse mechanisms including reducing Intereukin-6, Interleukin-8, Tumour Necrosis Factor-alpha besides controlli...
Autores principales: | Dalili, Nooshin, Kashefizadeh, Alireza, Nafar, Mohsen, Poorrezagholi, Fatemeh, Firouzan, Ahmad, Samadian, Fariba, Samavat, Shiva, Ziaie, Shadi, Fatemizadeh, Somayeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273823/ https://www.ncbi.nlm.nih.gov/pubmed/32503620 http://dx.doi.org/10.1186/s13063-020-04455-3 |
Ejemplares similares
-
Immunogenicity and Safety of SpikoGen, an Adjuvanted Recombinant SARS-CoV-2 Spike Protein, as a Heterologous Third Booster Dose in Kidney Transplant Patients: A Single-arm Clinical Trial
por: Nafar, Mohsen, et al.
Publicado: (2022) -
Agreement between the results of tuberculin skin test and Interferon-Gamma Release Assays in renal transplant candidates
por: Samavat, Shiva, et al.
Publicado: (2021) -
Clinical outcomes of kidney recipients with COVID-19 (COVID-19 in kidney recipients)
por: Hajibaratali, Bahareh, et al.
Publicado: (2023) -
Lopinavir/ritonavir monotherapy in clinical practice
por: Caso, A, et al.
Publicado: (2010) -
Lopinavir-Ritonavir-Kombination nicht wirksam
por: Diener, Hans-Christoph
Publicado: (2020)